Atlas Trials

Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo

Clinical trial NCT02240693 · COMPLETED

Trial details

NCT number
NCT02240693
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2015-01-15
Primary completion
2017-09-18
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.